Use of Homeopathy in Patients Suffering From Long COVID-19

NCT ID: NCT06002230

Last Updated: 2023-08-22

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 15 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-01-05
• Study Completion Date: 2023-08-10

Brief Summary

In some patients, coronavirus (COVID-19) can cause symptoms that last weeks or even months after the infection has gone. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to Long-COVID-19 patients with previously confirmed symptomatic SARS-CoV-2 infection.

Detailed Description

All patients had been tested positive for SARS-CoV-2 before having developed Long-COVID-19 symptoms. Several testing methods were carried out in each patient to analyze a SARS-CoV-2 infection. For a confirmed infection, at least 3 out of these 5 tests had to be positive. Tests for the orthomyxoviruses influenza A and B, human metapneumovirus (hMPV) and paramyxoviruses were negative unless stated otherwise.

The homeopathic physician treated all Long-COVID-19 patients by individualized homeopathy. Repertorization of the symptoms of the current pandemic and a search in the current homeopathic literature on COVID-19 was performed using computer program. All available homeopathic medicinal products (HMPs) could be chosen by the treating physician.

Modified MONARCH criteria were assessed post hoc by all authors. Deviations were solved by discussion in person. Clinical outcome of case reports was evaluated using the "Modified Naranjo Criteria for Homeopathy-Causal Attribution Inventory". Eight points is assumed as the limit for potential correlation between homeopathic therapy and amelioration of the symptoms or healing in chronic cases.

Conditions

Adjustment Reaction With Physical Symptoms

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: RETROSPECTIVE

Study Groups

Patients treated with individualized homeopathy

Patients suffering from symptoms of Long COVID-19 were treated with individualized homeopathy.

Homeopathic medicines

Intervention Type: DRUG

Globules were administered orally..

Interventions

Homeopathic medicines

Globules were administered orally..

Intervention Type: DRUG

Other Intervention Names

Homeopathic medicinal products

Eligibility Criteria

Inclusion Criteria

Long COVID-19 symptoms following recovery from SARS-CoV-2 infection

Exclusion Criteria

Patients not signing informed consent

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 100 Years
• Eligible Sex: FEMALE
• Accepts Healthy Volunteers: No

Sponsors

Sigmund Freud PrivatUniversitat

OTHER

Sponsor Role: collaborator

Michael Frass

OTHER

Sponsor Role: lead

Responsible Party

Michael Frass

Clinical professor

Responsibility Role: SPONSOR_INVESTIGATOR

Principal Investigators

Michael Frass, MD

Role: STUDY_DIRECTOR

Institute for Homeopathic Research

Locations

Sigmund Freud Private University

Vienna, , Austria

Countries

Austria

Other Identifiers

111

Identifier Type: -

Identifier Source: org_study_id